The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such se… read more
AdvisorShares
ETF
Equity
- years
26 holdings
$19.15
Price+0.88%
$0.17
$14.178m
Small
$25.139k
Avg Volume$7.055m
$13.06
NAV0.60%
Expense Ratio1.04%
Yield$0.20
Dividend